Thane Wettig

Thane Wettig serves as Chief Executive Officer at FibroGen, Inc.. FibroGen, Inc. operates in the research sector with approximately 320.0 employees. The company is headquartered in Indianapolis, Indiana. FibroGen, Inc. generates annual revenue of 29621000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at FibroGen, Inc..
• • 832 executive contacts are available in Indiana.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Outlook CloudFlare Hosting Atlassian Cloud OneTrust React Salesforce Barracuda Networks Remote AI

anemia chronic kidney disease fibrotic disease duchenne muscular dystrophy pancreatic cancer hifphi antictgf biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceuticals innovative therapeutics anemia treatment cancer therapies fibrotic diseases roxadustat pamrevlumab hypoxia-inducible factor oncology rare diseases nephrology patient-centric approach scientific innovation clinical trials drug development global operations partnerships astrazeneca fortis therapeutics healthcare providers patient demographics market segmentation therapeutic priorities research & development life-threatening conditions pharmaceutical industry healthcare institutions chronic diseases patient empowerment integrity respect collaborative culture market research multichannel marketing customer profiling geographic reach diversity & inclusion health wellness & fitness hospital & health care

KC

Kirk Christoffersen Chief Executive Officer & Chairman at FibroGen, Inc.

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Thane Wettig in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at FibroGen, Inc..

Thane Wettig's Position in the MessageCEO Database

• •Thane Wettig is 1 of 2 verified executive contacts we track at FibroGen, Inc..
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •768 verified executive contacts in Indiana are in the database.
• •14 verified contacts work at research companies in the 320.0 employee range (same size as FibroGen, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Thane Wettig directly?

Thane Wettig's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at FibroGen, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Thane Wettig work for?

Thane Wettig is Chief Executive Officer at FibroGen, Inc., a company in the research sector with 320.0 employees. The company is based in Indianapolis, Indiana.

Can I pitch or sell to Thane Wettig?

As Chief Executive Officer at FibroGen, Inc., Thane Wettig is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Thane Wettig directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Thane Wettig in?

Thane Wettig works in the research industry as Chief Executive Officer at FibroGen, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Thane Wettig's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Thane Wettig's profile is kept up-to-date with the latest available information.

Last updated: July 23, 2026